NRX Pharmaceuticals
NRXP
NRXP
30 hedge funds and large institutions have $2.07M invested in NRX Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less capital invested
Capital invested by funds: $3.44M → $2.07M (-$1.36M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
30
Holding in Top 10
–
Calls
$109K
Puts
$13K
Top Buyers
| 1 | +$34.9K | |
| 2 | +$34.3K | |
| 3 | +$30K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12K |
Top Sellers
| 1 | -$32.8K | |
| 2 | -$29.9K | |
| 3 | -$29K | |
| 4 |
HSA
HBK Sorce Advisory
Erie,
Pennsylvania
|
-$19.3K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$16.6K |